| International comparison of generic medicine prices. | |
| | |
MedLine Citation:
|
PMID: 17877848 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The introduction of generic price-regulated systems in many European countries, the trend towards international generic medicine companies, and competition from Indian companies emphasises the need to gain insight into international prices of generic medicines. OBJECTIVE: This study aims to carry out an international comparison of ex-manufacturer prices of generic medicines in ambulatory care in nine European countries and in India in 2005. METHODS: Data on ex-manufacturer prices of generic medicines of 15 molecules/strengths were derived from IMS Health. Belgian prices were compared with prices observed in Denmark, France, Germany, India, The Netherlands, Norway, Spain, Sweden and the United Kingdom. The analysis was limited to medicines in immediate-release, oral, solid dosage forms. RESULTS: India and the Scandinavian countries had the lowest ex-manufacturer prices of generic medicines of selected molecule/strengths. These molecule/strengths were, on average, 63% cheaper in India than in Belgium. The highest price levels were observed in France, The Netherlands and Germany. Ex-manufacturer prices of a specific generic molecule/strength varied between countries by a factor of 3 to 36, depending on the molecule/strength. The generic medicine price level was higher in countries that adopt a free market approach and in countries that have a mature generic medicine market. CONCLUSIONS: Ex-manufacturer prices of selected molecule/strengths varied substantially between countries. India has emerged as a low-cost producer of generic medicines. The international price comparison reveals that there may be scope for reducing generic medicine prices in a number of countries. |
| | |
Authors:
|
Steven Simoens |
Related Documents
:
|
21963568 - Zootherapeutic practices in aquismón, san luis potosí, méxico. 4549348 - Population replacement in culex fatigens by means of cytoplasmic incompatibility. labor... 3256648 - Collection of urine specimens in general practice: to clean or not to clean? 21660228 - Update on pharmaceutical and minimally invasive management strategies for chronic obstr... 12695798 - The cardioop-data clas (cdc). development and application of a thesaurus for content ma... 16176738 - Does the north staffordshire slot system control demand of orthopaedic referrals from p... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Current medical research and opinion Volume: 23 ISSN: 1473-4877 ISO Abbreviation: Curr Med Res Opin Publication Date: 2007 Nov |
Date Detail:
|
Created Date: 2007-11-02 Completed Date: 2008-01-16 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0351014 Medline TA: Curr Med Res Opin Country: England |
Other Details:
|
Languages: eng Pagination: 2647-54 Citation Subset: IM |
Affiliation:
|
Research Centre for Pharmaceutical Care and Pharmaco-economics, Katholieke Universiteit Leuven, Belgium. steven.simoens@pharm.kuleuven.be |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Drug Costs Drugs, Generic / economics* Europe India Internationality* |
| Chemical | |
Reg. No./Substance:
|
0/Drugs, Generic |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Integration of novel agents into treatment of myeloma.
Next Document: Communication and laboratory performance in parapsychology experiments: demand characteristics and t...